Edge Pharma Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 73.10 Cr
as on 01-01-2025
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -22.03%
(FY 2021)
- Profit -299.07%
(FY 2021)
- Ebitda -1329.47%
(FY 2021)
- Net Worth -1434.16%
(FY 2021)
- Total Assets -2.13%
(FY 2021)
About Edge Pharma
The Corporate was formerly known as Faldrup Investments And Traders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 73.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Edge Pharma Private Limited India is Anita Vyas as COMPANY SECRETARY. Sameer Chandurkar, Jayshree Chandurkar, and Manish Shah serve as directors at the Company.
- CIN/LLPIN
U67120MH1989PTC053742
- Company No.
053742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Edge Pharma Private Limited offer?
Edge Pharma Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Edge Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Vyas  | Company Secretary | 07-Aug-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Chandurkar | Director | 01-Apr-2009 | Current |
| Jayshree Chandurkar | Director | 09-Apr-2014 | Current |
| Manish Shah | Director | 17-Feb-2021 | Current |
Financial Performance of Edge Pharma.
Edge Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.03% decrease. The company also saw a substantial fall in profitability, with a 299.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1434.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edge Pharma?
In 2021, Edge Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Brickstreet Technologies LlpActive 3 years 3 months
Sameer Chandurkar and Jayshree Chandurkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edge Pharma?
Edge Pharma has a workforce of 33 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edge Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edge Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
